{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:51:10Z","timestamp":1772524270172,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"S8","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1186\/s12859-016-1116-4","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T07:23:57Z","timestamp":1472628237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction"],"prefix":"10.1186","volume":"17","author":[{"given":"Xiaojun","family":"Xu","sequence":"first","affiliation":[]},{"given":"Hong","family":"Thai","sequence":"additional","affiliation":[]},{"given":"Kathryn M.","family":"Kitrinos","sequence":"additional","affiliation":[]},{"given":"Guoliang","family":"Xia","sequence":"additional","affiliation":[]},{"given":"Anuj","family":"Gaggar","sequence":"additional","affiliation":[]},{"given":"Matthew","family":"Paulson","sequence":"additional","affiliation":[]},{"given":"Lilia","family":"Ganova-Raeva","sequence":"additional","affiliation":[]},{"given":"Yury","family":"Khudyakov","sequence":"additional","affiliation":[]},{"given":"James","family":"Lara","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"1116_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","volume":"8","author":"L Menendez-Arias","year":"2014","unstructured":"Menendez-Arias L, Alvarez M, Pacheco B. Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance. Curr Opin Virol. 2014;8:1\u20139.","journal-title":"Curr Opin Virol"},{"issue":"4","key":"1116_CR2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40620-015-0214-0","volume":"28","author":"G Coppolino","year":"2015","unstructured":"Coppolino G et al. The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists. J Nephrol. 2015;28(4):393\u2013402.","journal-title":"J Nephrol"},{"issue":"6","key":"1116_CR3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/095632029700800610","volume":"8","author":"MN Arimilli","year":"1997","unstructured":"Arimilli MN et al. Synthesis, in vitro biological evaluation and oral bioavailability of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) prodrugs. Antivir Chem Chemother. 1997;8(6):557\u201364.","journal-title":"Antivir Chem Chemother"},{"issue":"3","key":"1116_CR4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","volume":"42","author":"BL Robbins","year":"1998","unstructured":"Robbins BL et al. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob Agents Chemother. 1998;42(3):612\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4-7","key":"1116_CR5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1081\/NCN-100002483","volume":"20","author":"MD Miller","year":"2001","unstructured":"Miller MD et al. Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples. Nucleosides Nucleotides Nucleic Acids. 2001;20(4-7):1025\u20138.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"4","key":"1116_CR6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/mp900036s","volume":"6","author":"L Durand-Gasselin","year":"2009","unstructured":"Durand-Gasselin L et al. Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys. Mol Pharm. 2009;6(4):1145\u201351.","journal-title":"Mol Pharm"},{"issue":"16","key":"1116_CR7","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2165\/10482940-000000000-00000","volume":"69","author":"CM Perry","year":"2009","unstructured":"Perry CM, Simpson D. Tenofovir disoproxil fumarate: in chronic hepatitis B. Drugs. 2009;69(16):2245\u201356.","journal-title":"Drugs"},{"issue":"7","key":"1116_CR8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.biocel.2012.04.006","volume":"44","author":"E Michailidis","year":"2012","unstructured":"Michailidis E et al. Antiviral therapies: focus on hepatitis B reverse transcriptase. Int J Biochem Cell Biol. 2012;44(7):1060\u201371.","journal-title":"Int J Biochem Cell Biol"},{"key":"1116_CR9","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1038\/emi.2013.56","volume":"2","author":"SA Jones","year":"2013","unstructured":"Jones SA, Hu J. Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention. Emerg Microbes Infect. 2013;2:e56.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"1116_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3350\/cmh.2015.21.1.41","volume":"21","author":"SK Jung","year":"2015","unstructured":"Jung SK et al. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naive and nucleos(t)ide analogue-experienced chronic hepatitis B patients. Clin Mol Hepatol. 2015;21(1):41\u20138.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"1116_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.26686","volume":"59","author":"KM Kitrinos","year":"2014","unstructured":"Kitrinos KM et al. No detectable resistance to tenofovir disoproxil fumarate after 6\u00a0years of therapy in patients with chronic hepatitis B. Hepatology. 2014;59(2):434\u201342.","journal-title":"Hepatology"},{"issue":"6","key":"1116_CR12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/jgh.12213","volume":"28","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Asselah T. Long-term therapy for chronic hepatitis B: hepatitis B virus DNA suppression leading to cirrhosis reversal. J Gastroenterol Hepatol. 2013;28(6):912\u201323.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1116_CR13","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/AAC.02600-12","volume":"57","author":"B Baran","year":"2013","unstructured":"Baran B et al. Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside\/nucleotide analogue-naive patients with chronic hepatitis B. Antimicrob Agents Chemother. 2013;57(4):1790\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"50","key":"1116_CR14","doi-asserted-by":"crossref","first-page":"35092","DOI":"10.1074\/jbc.M109.022525","volume":"284","author":"K Das","year":"2009","unstructured":"Das K et al. Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J Biol Chem. 2009;284(50):35092\u2013100.","journal-title":"J Biol Chem"},{"issue":"1","key":"1116_CR15","doi-asserted-by":"crossref","first-page":"e16242","DOI":"10.1371\/journal.pone.0016242","volume":"6","author":"A Hachiya","year":"2011","unstructured":"Hachiya A et al. K70Q adds high-level tenofovir resistance to \u201cQ151M Complex\u201d HIV reverse transcriptase through the enhanced discrimination mechanism. PLoS One. 2011;6(1):e16242.","journal-title":"PLoS One"},{"issue":"3","key":"1116_CR16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/AAC.48.3.992-1003.2004","volume":"48","author":"KL White","year":"2004","unstructured":"White KL et al. Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations. Antimicrob Agents Chemother. 2004;48(3):992\u20131003.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1116_CR17","doi-asserted-by":"crossref","first-page":"e106324","DOI":"10.1371\/journal.pone.0106324","volume":"9","author":"FJ Hemert van","year":"2014","unstructured":"van Hemert FJ, Berkhout B, Zaaijer HL. Differential binding of tenofovir and adefovir to reverse transcriptase of hepatitis B virus. PLoS One. 2014;9(9):e106324.","journal-title":"PLoS One"},{"issue":"10","key":"1116_CR18","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/JVI.75.10.4771-4779.2001","volume":"75","author":"K Das","year":"2001","unstructured":"Das K et al. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J Virol. 2001;75(10):4771\u20139.","journal-title":"J Virol"},{"issue":"5","key":"1116_CR19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nsmb760","volume":"11","author":"S Tuske","year":"2004","unstructured":"Tuske S et al. Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol. 2004;11(5):469\u201374.","journal-title":"Nat Struct Mol Biol"},{"key":"1116_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008;9:40.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"1116_CR21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 2010;5(4):725\u201338.","journal-title":"Nat Protoc"},{"issue":"12","key":"1116_CR22","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1093\/nar\/gku487","volume":"42","author":"K Das","year":"2014","unstructured":"Das K et al. Structures of HIV-1 RT-RNA\/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA\/DNA: insights into requirements for RNase H cleavage. Nucleic Acids Res. 2014;42(12):8125\u201337.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"1116_CR23","doi-asserted-by":"crossref","first-page":"W308","DOI":"10.1093\/nar\/gku369","volume":"42","author":"D Xu","year":"2014","unstructured":"Xu D et al. AIDA: ab initio domain assembly server. Nucleic Acids Res. 2014;42(Web Server issue):W308\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1116_CR24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/ci600406v","volume":"47","author":"M Naim","year":"2007","unstructured":"Naim M et al. Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space. J Chem Inf Model. 2007;47(1):122\u201333.","journal-title":"J Chem Inf Model"},{"issue":"9","key":"1116_CR25","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1021\/ci2000242","volume":"51","author":"T Sulea","year":"2011","unstructured":"Sulea T, Cui Q, Purisima EO. Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 2. Benchmark in the CSAR-2010 scoring exercise. J Chem Inf Model. 2011;51(9):2066\u201381.","journal-title":"J Chem Inf Model"},{"key":"1116_CR26","doi-asserted-by":"crossref","unstructured":"Lara, J., et al., P0633 : Association of hepatitis B virus genetic diversity with tenofovir disoproxil fumarate response rates in immune tolerant chronic hepatitis B patients. Journal of Hepatology. 2015;62: p. S556.","DOI":"10.1016\/S0168-8278(15)30838-2"},{"issue":"5-6","key":"1116_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/ISB-2012-0452","volume":"11","author":"DS Campo","year":"2011","unstructured":"Campo DS et al. Coordinated evolution of the hepatitis B virus polymerase. In Silico Biol. 2011;11(5-6):175\u201382.","journal-title":"In Silico Biol"},{"issue":"7312","key":"1116_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nature09326","volume":"467","author":"A Eldar","year":"2010","unstructured":"Eldar A, Elowitz MB. Functional roles for noise in genetic circuits. Nature. 2010;467(7312):167\u201373.","journal-title":"Nature"},{"key":"1116_CR29","doi-asserted-by":"crossref","unstructured":"Sharma, S.V., et al., A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations. Cell. 2010;141(1): p. 69-80.","DOI":"10.1016\/j.cell.2010.02.027"},{"issue":"18","key":"1116_CR30","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1093\/nar\/gku819","volume":"42","author":"GD Schauer","year":"2014","unstructured":"Schauer GD et al. Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence. Nucleic Acids Res. 2014;42(18):11687\u201396.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1116_CR31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/pro.359","volume":"19","author":"PR Daga","year":"2010","unstructured":"Daga PR, Duan J, Doerksen RJ. Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations. Protein Sci. 2010;19(4):796\u2013807.","journal-title":"Protein Sci"},{"issue":"2","key":"1116_CR32","doi-asserted-by":"crossref","first-page":"e9195","DOI":"10.1371\/journal.pone.0009195","volume":"5","author":"AW Walsh","year":"2010","unstructured":"Walsh AW et al. Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir. PLoS One. 2010;5(2):e9195.","journal-title":"PLoS One"},{"issue":"23","key":"1116_CR33","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1128\/JVI.75.23.11827-11833.2001","volume":"75","author":"X Lin","year":"2001","unstructured":"Lin X et al. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol. 2001;75(23):11827\u201333.","journal-title":"J Virol"},{"issue":"Web Server issu","key":"1116_CR34","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35(Web Server issue):W407\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1116_CR35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2014.01.044","volume":"146","author":"HL Chan","year":"2014","unstructured":"Chan HL et al. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA. Gastroenterology. 2014;146(5):1240\u20138.","journal-title":"Gastroenterology"},{"issue":"1","key":"1116_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.molbev.a026036","volume":"16","author":"HJ Bandelt","year":"1999","unstructured":"Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16(1):37\u201348.","journal-title":"Mol Biol Evol"},{"key":"1116_CR37","first-page":"Unit 5 6","volume":"Chapter 5","author":"N Eswar","year":"2006","unstructured":"Eswar N et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics. 2006;Chapter 5:Unit 5 6.","journal-title":"Curr Protoc Bioinformatics"},{"key":"1116_CR38","doi-asserted-by":"crossref","first-page":"5 6 1","DOI":"10.1002\/0471250953.bi0506s47","volume":"47","author":"B Webb","year":"2014","unstructured":"Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics. 2014;47:5 6 1\u20135 6 32.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"16","key":"1116_CR39","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case DA et al. The Amber biomolecular simulation programs. J Comput Chem. 2005;26(16):1668\u201388.","journal-title":"J Comput Chem"},{"issue":"1","key":"1116_CR40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0263-7855(90)80070-V","volume":"8","author":"G Vriend","year":"1990","unstructured":"Vriend G. WHAT IF: a molecular modeling and drug design program. J Mol Graph. 1990;8(1):52\u20136. 29.","journal-title":"J Mol Graph"},{"issue":"2","key":"1116_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):10.","journal-title":"J Chem Phys"},{"key":"1116_CR42","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U et al. A smooth particle mesh Ewald method. J Chem Phys. 1995;103:8577\u201393.","journal-title":"J Chem Phys"},{"issue":"3","key":"1116_CR43","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1063\/1.463137","volume":"97","author":"M Tuckerman","year":"1992","unstructured":"Tuckerman M, Berne BJ, Martyna GJ. Reversible multiple time scale molecular-dynamics. J Chem Phys. 1992;97(3):1990\u20132001.","journal-title":"J Chem Phys"},{"issue":"1","key":"1116_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/jcph.1999.6201","volume":"151","author":"L Kale","year":"1999","unstructured":"Kale L et al. NAMD2: Greater scalability for parallel molecular dynamics. J Comput Phys. 1999;151(1):283\u2013312.","journal-title":"J Comput Phys"},{"key":"1116_CR45","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips JC et al. Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26:1781\u2013802.","journal-title":"J Comput Chem"},{"issue":"9","key":"1116_CR46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J et al. Development and testing of a general amber force field. J Comput Chem. 2004;25(9):1157\u201374.","journal-title":"J Comput Chem"},{"issue":"2","key":"1116_CR47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J et al. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006;25(2):247\u201360.","journal-title":"J Mol Graph Model"},{"issue":"3","key":"1116_CR48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak V et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 2006;65(3):712\u201325.","journal-title":"Proteins"},{"issue":"7","key":"1116_CR49","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9(7):3084\u201395.","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"1116_CR50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph Model. 1996;14(1):33\u20138.","journal-title":"J Mol Graph Model"},{"issue":"3","key":"1116_CR51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/protein\/7.3.385","volume":"7","author":"J Aqvist","year":"1994","unstructured":"Aqvist J, Medina C, Samuelsson JE. A new method for predicting binding affinity in computer-aided drug design. Protein Eng. 1994;7(3):385\u201391.","journal-title":"Protein Eng"},{"issue":"10","key":"1116_CR52","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/jm960684e","volume":"40","author":"DK Jones-Hertzog","year":"1997","unstructured":"Jones-Hertzog DK, Jorgensen WL. Binding affinities for sulfonamide inhibitors with Human Thrombin Using Monte Carlo Simulations with a linear response method. J Med Chem. 1997;40(10):1539\u201349.","journal-title":"J Med Chem"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1116-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:44:52Z","timestamp":1749570292000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-016-1116-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":52,"journal-issue":{"issue":"S8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1186\/s12859-016-1116-4","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]},"article-number":"280"}}